Clinical trial
Glutaminergic Transmission in Autism : Molecular Imaging Exploration
NCT02719951 is registered in ClinicalTrials.gov with University Hospital, Tours as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Glutaminergic Transmission in Autism : Molecular Imaging Exploration
- Lead sponsor
- University Hospital, Tours
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- April 30, 2016
- Completion date
- May 31, 2019
- Enrollment
- 27 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
autism, fragile-x syndrome (fxs), healthy volunteers